Adis Santoyo Banasco
Family · Atlantis, FLNPI 1568240034
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 218 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 17.7% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,354, 6.5 times the $364 reported in 2023. Among family clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 218 payments — averaging $21.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$838
- AstraZeneca$763
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$430
- Otsuka America Pharmaceutical, Inc.$405
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$296
- Takeda Pharmaceuticals U.S.A., Inc.$233
- plus $2K from 23 others
What the payments were for
- Food & beverage$4,720100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 42 | $838 |
| AstraZeneca | 28 | $763 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 21 | $430 |
| Otsuka America Pharmaceutical, Inc. | 17 | $405 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 16 | $296 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $233 |
| Sumitomo Pharma America, Inc. | 9 | $189 |
| Teva Pharmaceuticals USA, Inc. | 11 | $184 |
| Vanda Pharmaceuticals Inc. | 6 | $168 |
| Exact Sciences | 6 | $150 |
| Amgen | 6 | $137 |
| Bayer | 5 | $129 |
| GSK | 6 | $124 |
| Novo Nordisk | 6 | $112 |
| Kowa Pharmaceuticals America, Inc. | 4 | $86 |
| Viiv Healthcare Company | 3 | $79 |
| Dexcom, Inc. | 4 | $75 |
| Lilly USA, LLC | 3 | $56 |
| Xeris Pharmaceuticals, Inc. | 3 | $56 |
| Pfizer | 2 | $37 |
| Mylan Specialty L.p. | 1 | $23 |
| Almatica Pharma LLC | 1 | $23 |
| Corcept Therapeutics | 1 | $20 |
| Verity Pharmaceuticals Inc. | 1 | $20 |
| Lundbeck LLC | 1 | $20 |
| Verona Pharma, Inc. | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Tolmar, Inc. | 1 | $14 |
| Esperion Therapeutics, Inc. | 1 | $14 |
How this compares
$4,720 in reported general payments places this provider in the 90th percentile of 14,618 family providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rosuvastatin Calcium | 26 | $476 |
| Diclofenac Sodium | 26 | $201 |
| Fluticasone Propionate | 13 | $155 |
| Amitriptyline Hcl | 16 | $134 |
| Doxycycline Hyclate | 11 | $109 |
| Metformin Hcl | 17 | $101 |
| Azithromycin | 23 | $81 |
| Amlodipine Besylate | 17 | $75 |
| Atorvastatin Calcium | 13 | $46 |
| Escitalopram Oxalate | 11 | $39 |
| Levothyroxine Sodium | 13 | $35 |
| Prednisone | 12 | $32 |
Paid to pharmacies, not to this prescriber.
Other family in Atlantis
- Lewis HarringtonTampa$954K
- Danielle PharesFt Lauderdale$713K
- Donna OrtizOrlando$417K
- Patrick SzarazMiami$327K
- Deena RodneyMaitland$323K
- Yamila MelendezMiami$212K
- Holly BoydLand O Lakes$200K
- Rachael BuschLoxahatchee$189K
- Victor Tatis de la NuezMiramar$161K
- Ronda CrewsJax Bch$155K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.